Recent Updates
Recently added Catalysts

Mylan Fentanyl System/h+ Scotch Duct Tape

Phase 1

Healthy | Small molecule | Other |Viatris Inc.|Last Updated: Apr 23, 2024

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedCONTROLLEDBiomarker
Total Trials1
Total Enrollment12

FDA Designations

No designations recorded

Clinical trial landscape

Mylan Fentanyl System/h+ Scotch Duct Tape · 1 trial · 1 indication

Phase 1 1
NCT00650117Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal SystemHealthy
COMPLETED12 Analytics
PHASE1COMPLETED
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System
HealthyUnlock trial analytics

Study Endpoints

Primary Endpoints

Drug Delivery
within 30 days
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeOTHER

Treatment Arms

ArmTypeDescription
1EXPERIMENTALMylan Fentanyl Transdermal System 25 mcg/h + Scotch Duct Tape (3M)
2EXPERIMENTALMylan Fentanyl Transdermal System 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M)
3EXPERIMENTALMylan Fentanyl Transdermal System 25 mcg/h + Microfoam Tape (3M)
4EXPERIMENTALDuragesic 25 mcg/h + Scotch Duct Tape (3M)
5EXPERIMENTALDuragesic 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M)
6EXPERIMENTALDuragesic 25 mcg/h + Microfoam Tape (3M)

Interventions

NameTypeDescription
Mylan Fentanyl Transdermal System 25 mcg/h + Scotch Duct Tape (3M)DRUGsingle application
Duragesic 25 mcg/h + Scotch Duct Tape (3M)DRUGsingle application
Mylan Fentanyl Transdermal System 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M)DRUGsingle application
Duragesic 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M)DRUGsingle application
Mylan Fentanyl Transdermal System 25 mcg/h + Microfoam Tape (3M)DRUGsingle application
Duragesic 25 mcg/h + Microfoam Tape (3M)DRUGsingle application
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female. 1. Women of childbearing potential must have negative serum beta human chorionic gonadotropin (beta-HCG) pregnancy tests performed within 21 days prior to the start of the study and on the ev...

Countries:United States
Unlock Eligibility Criteria